Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,954 DKK | +60.52% | +4.14% | +14.24% |
04:19pm | Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study | MT |
04:00pm | Transcript : Genmab A/S - Special Call |
- Stock Market
- Equities
- GMAB Stock
- Stock
- News Genmab
- Analyst Reco.